Pelvic sonography can predict ovum release in gonadotrophin-treated patients as determined by pregnancy rate.
Ultrasonographic monitoring of ovum release was performed in two consecutive cycles in each of 220 patients treated with gonadotrophin. Definite release occurred in 69% of cycles, indeterminate in 24% and non-release in 7%. Support for the accuracy of sonography in diagnosing the luteinized unruptured follicle (LUF) was demonstrated by a much higher pregnancy rate in those patients showing ovum release. There was a definite tendency for non-release to recur in the next cycle. Thus, the data support the routine use of sonography 2-3 days after human chorionic gonadotrophin (HCG) injection to monitor ovum release in gonadotrophin-treated patients (HMG).
Check
J H
JH
UMDNJ, Robert Wood Johnson Medical School, Camden, NJ.
Adelson
H G
HG
Dietterich
C
C
Stern
J
J
D006063:Chorionic Gonadotropin / Q000494:pharmacology; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000502:physiology; D008596:Menotropins / Q000494:pharmacology / Q000627:therapeutic use; D006080:Ovarian Follicle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D012189:Retrospective Studies; D014463:Ultrasonography
D006063:Chorionic Gonadotropin; D008596:Menotropins